Moon Capital Management identifies Molina Healthcare as a mispriced compounder poised for recovery as Medicaid margins ...
The FDA delayed reviews of two drugs chosen for the Trump administration's new fast-track program after agency scientists ...
Pharmaceutical Technology on MSN
Compounder sues Lilly and Novo for suppressing GLP-1RA competition
Strive Compounding Pharmacy alleges the two pharma companies are coordinating an effort to restrict compounded access.
Strive Compounding Pharmacy alleged in its lawsuit that Eli Lilly and Novo Nordisk have worked to lock telehealth providers ...
A compounding pharmacy has filed a lawsuit accusing Eli Lilly and Novo Nordisk of using anticompetitive tactics to prevent it ...
In recent months, Kirby Corp has reported steadier demand for its inland and coastal tank barge services, supported by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results